Circulating Hepcidin Is Independently Associated with Systolic Blood Pressure in Apparently Healthy Individuals

Archives of Medical Research

Volumn 46, Issue 6, 2015, Pages 507-513

  Suárez Ortegón, Milton Fabian ^a,b   Arbeláez, Alejandra ^b   Mosquera, Mildrey ^b   Moreno Navarrete, José Maria ^c   Aguilar Plata, Cecilia ^b   Fernández Real, José Manuel ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSIDAD DEL VALLE   (Colombia)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Blood pressure; Cardiovascular risk; Hepcidin; Insulin resistance

Indexed keywords

GLUCOSE; HEPCIDIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; INSULIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; INSULIN RESISTANCE; MALE; NORMAL HUMAN; OUTCOME VARIABLE; PHYSICAL INACTIVITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMPLICATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEPCIDINS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 84941285172     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2015.07.007     Document Type: Article

References (18)

1. Vari I.S., Balkau B., Kettaneh A., et al. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007, 30:1795-1801.
2. Chern J.P., Lin K.H., Lu M.Y., et al. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetes Care 2001, 24:850-854.
3. Wrede C.E., Buettner R., Bollheimer L.C., et al. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol 2006, 154:333-340.
4. Lee B.K., Kim Y., Kim Y.I. Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008. Metabolism 2011, 60:1416-1424.
5. Forouhi N.G., Harding A.H., Allison M., et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007, 50:949-956.
6. Ganz T., Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 2006, 290:G199-G203.
7. Martinelli N., Traglia M., Campostrini N., et al. Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. PLoS One 2012, 7:e48250.
8. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
9. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
10. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
11. Fernández-Real J.M., Equitani F., Moreno J.M., et al. Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores. J Clin Endocrinol Metab 2009, 94:982-988.
12. Jiang F., Sun Z.Z., Tang Y.T., et al. Hepcidin expression and iron parameters change in type 2 diabetic patients. Diabetes Res Clin Pract 2011, 93:43-48.
13. Galesloot T.E., Holewijn S., Kiemeney L.A., et al. Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population. Arterioscler Thromb Vasc Biol 2014, 34:446-456.
14. Sander D., Kukla C., Klingelhöfer J., et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000, 26:1536-1541.
15. Valenti L., Dongiovanni P., Motta B.M., et al. Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol 2011, 31:683-690.
16. Li J.J., Meng X., Si H.P., et al. Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis. Arterioscler Thromb Vasc Biol 2012, 32:1158-1166.
17. Pham N.M., Nanri A., Yi S., Kurotani K., et al. Serum ferritin is associated with markers of insulin resistance in Japanese men but not in women. Metabolism 2013, 62:561-567.
18. Galesloot T.E., Vermeulen S.H., Geurts-Moespot A.J., et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011, 117:e218-e225.